Tian-Li Wang

Medicine & Life Sciences

1. Carcinoma 100%
2. Ovarian Neoplasms 99%
3. Neoplasms 74%
4. Mutation 42%
5. Carcinoma in Situ 32%
6. Genes 30%
7. Chromatin Assembly and Disassembly 28%
8. Endometrioid Carcinoma 28%
9. Fallopian Tubes 26%
10. Endometrial Neoplasms 19%
11. Proteins 18%
12. Epithelium 18%
13. Genome 17%
14. Karyotyping 16%
15. GABA Receptors 14%
16. DNA 14%
17. Carcinogenesis 14%
18. Endometrium 13%
19. gamma-Aminobutyric Acid 12%
20. DNA Copy Number Variations 12%
21. Endometriosis 12%
22. Colorectal Neoplasms 11%
23. Transcriptome 11%
24. Paclitaxel 11%
25. Growth 11%
26. Breast Neoplasms 11%
27. Telomere 10%
28. Survival 10%
29. DNA Vaccines 10%
30. Epithelial Cells 9%
31. Cell Line 9%
32. Gene Expression 9%
33. Cell Proliferation 9%
34. Syk Kinase 9%
35. Aminobutyrates 9%
36. Retina 8%
37. Immunohistochemistry 8%
38. Up-Regulation 8%
39. Staining and Labeling 8%
40. Xenopus 8%
41. DNA Damage 8%
42. Oocytes 8%
43. Phenotype 7%
44. Poly(ADP-ribose) Polymerase Inhibitors 7%
45. Chromatin Immunoprecipitation Sequencing 7%
46. Gene Amplification 7%
47. Hyperplasia 7%
48. Telomerase 7%
49. Neoplasm Genes 7%
50. Human Genome 7%